LIVE, ORALLY GIVEN POLIOVIRUS VACCINE: EFFECTS OF RAPID MASS IMMUNIZATION ON POPULATION UNDER CONDITIONS OF MASSIVE ENTERIC INFECTION WITH OTHER VIRUSES
Abstract
The phenomenon of viral interference must be taken into account in planning the use of live poliovirus vaccine in areas where conditions favor the extensive dissemination of naturally occurring polioviruses. Experience with feeding a trivalent vaccine to 26,033 children in a tropical city of 100, 000 population led to the conclusion that interference was overcome by mass feeding of vaccine to 86% of all children under 11 years within a period of about four days, and that, because dissemination of the poliovirus was self-limited, a second feeding of trivalent vaccine was necessary to achieve immunization of almost all children. Recommendations are here formulated for the eradication of poliomyelitis, but they apply only to subtropical and tropical regions with extensive dissemination of various enteric viruses and not to temperate zones with good sanitation and hygiene during certain periods of the year and under conditions of low or absent dissemination of enteric viruses.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the United States, the incidence of paralytic polio fell from 13,850 in 1955 to 829 in 1961.
“In the United States, for example, the incidence of paralytic polio fell from 13,850 in 1955 to 829 in 1961 (175).”
From VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION (2005) · cites this paper as [175]
Cited by
Sorted by citations
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION
Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., & Pallansch, M. A. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123625 · Cited by 703 · see citing works
Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: Review.
Patriarca, P. A., Wright, P. F., & John, T. J. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.5.926 · Cited by 453 · see citing works
From Emergence to Eradication: The Epidemiology of Poliomyelitis Deconstructed
Nathanson, N., & Kew, O. M. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq320 · Cited by 405 · see citing works
“When OPV is administered to children who are concurrently infected with other enteroviruses, the proportion of vaccinees who become OPV-infected and develop an immune response against poliovirus is reduced (45).”
Background100 Citation Classics From The Journal of the American Medical Association
Garfield, E. (1987) · JAMA · doi:10.1001/jama.1987.03390010056028 · Cited by 356 · see citing works
Selective inhibitors of picornavirus replication
Palma, A. M. D., Vliegen, I., Clercq, E. D., & Neyts, J. H. (2008) · Medicinal Research Reviews · doi:10.1002/med.20125 · Cited by 258 · see citing works
Circulating vaccine-derived polioviruses: current state of knowledge.
Kew, O. M., Wright, P. F., Agol, V. I., Delpeyroux, F., Shimizu, H., Nathanson, N., & Pallansch, M. A. (2004) · Europe PMC (PubMed Central) · doi:10.1590/s0042-96862004000100006 · Cited by 256 · see citing works
“To counter the daunting challenges of delivering a live, attenuated RNA virus vaccine via its natural route of infection, immunization strategies were developed to minimize adverse events ( 1, 23 ).”
Fine, P. E. M., & Carneiro, I. A. M. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009924 · Cited by 247 · see citing works
Paralytic poliomyelitis: Seasoned strategies, disappearing disease
Hull, H. F., Ward, N. A., Hull, B. P., Milstien, J. B., Hull, H. F., & de Quadros, C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92472-4 · Cited by 235 · see citing works
Sutter, R. W., Kew, O. M., & Cochi, S. L. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50030-1 · Cited by 167 · see citing works
Two centuries of vaccination: historical and conceptual approach and future perspectives
Montero, D. A., Vidal, R. M., Velasco, J., Carreño, L. J., Torres, J. P., O., M. A. B., Tovar-Rosero, Y.-Y., Oñate, A. A., & O’Ryan, M. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1326154 · Cited by 160 · see citing works
“A few years later, in 1961, Sabin developed an oral polio vaccine (OPV) based on attenuated viruses (59).”
BackgroundThe Double-Edged Sword: How Evolution Can Make or Break a Live-Attenuated Virus Vaccine
Hanley, K. A. (2011) · Evolution Education and Outreach · doi:10.1007/s12052-011-0365-y · Cited by 125 · see citing works
“Such interference has long been recognized; Sabin and his colleagues (Sabin et al. 1960) pointed out that the individual components of OPV were more efficacious when administered individually (as monovalent vaccines) than when administered together in a trivalent vaccine.”
BackgroundExpert Review on Poliovirus Immunity and Transmission
Tebbens, R. J. D., Pallansch, M. A., Chumakov, K. M., Halsey, N. A., Hovi, T., Minor, P. D., Modlin, J. F., PATRIARCA, P. A., Sutter, R. W., Wright, P. F., et al. (2012) · Risk Analysis · doi:10.1111/j.1539-6924.2012.01864.x · Cited by 109 · see citing works
Recommendations for a National Policy on Poliomyelitis Vaccination
Nightingale, E. O. (1977) · New England Journal of Medicine · doi:10.1056/nejm197708042970505 · Cited by 108 · see citing works
Sutter, R. W., PATRIARCA, P. A., Cochi, S. L., Pallansch, M. A., Kew, O. M., Hall, D. B., BROGAN, S., Malankar, P., AL-GHASSANI, A. A. K., Suleiman, A. J. M., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)91442-w · Cited by 102 · see citing works
Monovalent Type 1 Oral Poliovirus Vaccine in Newborns
El-Sayed, N., El‐Gamal, Y., Abbassy, A.-A., Seoud, I., Salama, M., Kandeel, A., Hossny, E. M., Shawky, A., Hussein, H. A., Pallansch, M. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800390 · Cited by 83 · see citing works
Paralytic Poliomyelitis: Old Dogmas and New Perspectives
Sabin, A. B. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.3.543 · Cited by 83 · see citing works
“traordinarily high rate of viral dissemination early in life, had an average annual incidence of 14 recognized paralytic cases among a total population of 100,000; this rate is equivalent to 140 cases per million population [34].”
BackgroundMethodInfluentialSelf-citationCurrent view on novel vaccine technologies to combat human infectious diseases
Matić, Z., & Šantak, M. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11713-0 · Cited by 80 · see citing works
“Another is Sabin’s live attenuated oral vaccine (OPV) used from the 1960s of the last century (Sabin et al. 1960).”
BackgroundHistorical Development of the Journal Impact Factor and its Relevance for Occupational Health
SMITH, D. R. (2007) · Industrial Health · doi:10.2486/indhealth.45.730 · Cited by 76 · see citing works
Parker, E. P. K., Kampmann, B., Kang, G., & Grassly, N. C. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu182 · Cited by 74 · see citing works
“yielded contradictory results: while several reports have supported the interfering effects of concurrent nonpolio enteroviruses (NPEVs) [9, 10], bacteria [11], or diarrhea [12], others have refuted these effects [13–15].”
The final stages of the global eradication of poliomyelitis
Grassly, N. C. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2012.0140 · Cited by 74 · see citing works
Oral poliovirus vaccine. History of its development and prospects for eradication of poliomyelitis
Sabin, A. B. (1965) · JAMA · doi:10.1001/jama.194.8.872 · Cited by 74 · see citing works
Self-citationCitation classics in occupational medicine journals
Gehanno, J.-F., Takahashi, K., Darmoni, S. J., & Weber, J. (2007) · Scandinavian Journal of Work Environment & Health · doi:10.5271/sjweh.1139 · Cited by 73 · see citing works
“” As Garfield (1) noted, the landmark article by Sabin et al, from 1960 (16), on the use of oral poliomyelitis virus vaccine received only 90 citations up to 1987.”
BackgroundInterrupting the transmission of wild polioviruses with vaccines: immunological considerations.
(1994) · Europe PMC (PubMed Central) · Cited by 70 · see citing works
RANDOMISED TRIAL OF ALTERNATIVE FORMULATIONS OF ORAL POLIOVACCINE IN BRAZIL
Patriarca, P. A., Palmeira, G., Filho, J. L., Cordeiro, M. T., Laender, F., Oliveira, M. J. C., Dantes, M. C. D. S., Risi, J. B., & Orenstein, W. A. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91229-9 · Cited by 68 · see citing works
Molecular determinants of plaque size as an indicator of dengue virus attenuation
Goh, K. C. M., Tang, C. K., Norton, D. C., Gan, E. S., Tan, H. C., Sun, B., Syenina, A., Yousuf, A., Ong, X. M., Kamaraj, U. S., et al. (2016) · Scientific Reports · doi:10.1038/srep26100 · Cited by 64 · see citing works
“The process of generating attenuated strains has remained fundamentally unchanged since pioneering work by Sabin and others in developing the oral polio vaccine 26 .”
The “omnipotent” Science Citation Index Impact Factor
Lundberg, G. D. (2003) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2003.tb05188.x · Cited by 64 · see citing works
Diarrheal Diseases of Children
Ramos-Alvarez, M. (1964) · American journal of diseases of children · doi:10.1001/archpedi.1964.02080060220002 · Cited by 62 · see citing works
Dowdle, W., Van Der Avoort, H., De Gourville, E., Delpeyroux, F., Desphande, J., Hovi, T., Martin, J., Pallansch, M., Kew, O., & Wolff, C. (2006) · Risk Analysis · doi:10.1111/j.1539-6924.2006.00844.x · Cited by 61 · see citing works
“In temperate climates and/or populations with high levels of immunity, Sabin strains generally disappear from circulation within three to six months after pulse OPV vaccination(44,126,127,176,191) or removal of OPV from the environment.”
BackgroundSwartz, T. A., Skalska, P., Gerichter, C. G., & Cockburn, W. C. (1972) · Epidemiology and Infection · doi:10.1017/s0022172400022567 · Cited by 57 · see citing works
Sutter, R. W., Kew, O. M., Cochi, S. L., & Aylward, R. B. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00035-5 · Cited by 55 · see citing works
(2018) · Directory of Open access Books (OAPEN Foundation) · Cited by 54 · see citing works
The potential impact of expanding target age groups for polio immunization campaigns
Tebbens, R. J. D., Kalkowska, D. A., Wassilak, S. G. F., Pallansch, M. A., Cochi, S. L., & Thompson, K. M. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-45 · Cited by 53 · see citing works
Secretory and Serum Immunoglobulin Class-Specific Antibodies to Poliovirus After Vaccination
Carlsson, B., Zaman, S., Mellander, L., Jalil, F., & Hanson, L. Å. (1985) · The Journal of Infectious Diseases · doi:10.1093/infdis/152.6.1238 · Cited by 53 · see citing works
“Early exposure to antigen and the subsequent antibody response, as seen in the saliva and serum of the unvaccinated group, suggests the effectiveness of very early vaccination against poliomyelitis in endemic areas [17-22].”
BackgroundBergman, M. A., Loomis, W. P., Mecsas, J. C., Starnbach, M. N., & Isberg, R. R. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000573 · Cited by 51 · see citing works
“Prior exposure to attenuated pathogens can generate protective immunity against subsequent challenge with fully virulent organisms [45–47].”
BackgroundTriki, H., Abdallah, M. V. O. M., Aïssa, R. B., Bouratbine, A., Kacem, M., Bouraoui, S., Koubaa, C., Zouari, S., Mohsni, E., Crainic, R., et al. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00001-7 · Cited by 50 · see citing works
Community-Wide Use of Oral Poliovirus Vaccine
Sabin, A. B. (1961) · American journal of diseases of children · doi:10.1001/archpedi.1961.04020060004002 · Cited by 49 · see citing works
Self-citationCockburn, W. C., & Drozdov, S. G. (1970) · PubMed · Cited by 49 · see citing works
Sabin, A. B. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s391 · Cited by 48 · see citing works
“carried out in a few days in tropical communities with poor sanitation and hygiene only temporarily suppresses the amount of "wild" polioviruses [9].”
BackgroundSelf-citationWagner, R. R. (1965) · The American Journal of Medicine · doi:10.1016/0002-9343(65)90193-2 · Cited by 47 · see citing works
Sutter, R. W., PATRIARCA, P. A., Suleiman, A. J. M., BROGAN, S., Malankar, P., Cochi, S. L., AL-GHASSANI, A. A. K., & Elbualy, M. S. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/165.3.444 · Cited by 46 · see citing works
National Immunization Days: Experience in Latin America
Olive, J.-M., Risi, J. B., & de Quadrós, C. A. (1997) · The Journal of Infectious Diseases · doi:10.1093/infdis/175.supplement_1.s189 · Cited by 44 · see citing works
Matrix and Backstage: Cellular Substrates for Viral Vaccines
Jordan, I., & Sandig, V. (2014) · Viruses · doi:10.3390/v6041672 · Cited by 43 · see citing works
“Three vaccines were in development: a killed vaccine proposed by Salk [11] with virulent polioviruses as seed, and two live attenuated vaccines that were developed by Sabin [12] and by Koprowksi and Cox [13,14].”
BackgroundInfluentialAssessing the stability of polio eradication after the withdrawal of oral polio vaccine
Famulare, M., Selinger, C., McCarthy, K. A., Eckhoff, P. A., & Chabot‐Couture, G. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2002468 · Cited by 36 · see citing works
Sabin, A. B. (1962) · Royal Society of Health Journal · doi:10.1177/146642406208200205 · Cited by 36 · see citing works
Self-citationHighly Cited Articles in Environmental and Occupational Health, 1919–1960
SMITH, D. R. (2009) · Archives of Environmental & Occupational Health · doi:10.1080/19338240903286743 · Cited by 35 · see citing works
Kuramitsu, M., Kuroiwa, C., Yoshida, H., MIYOSHI, M., Okumura, J., Shimizu, H., Narantuya, L., & Bat-Ochir, D. (2005) · Epidemiology and Infection · doi:10.1017/s0950268805004139 · Cited by 34 · see citing works
“infections in reducing seroconversion rate has been repeatedly suggested [29-31], and low rates of seroconversion have been reported more frequently during summer than in winter [32, 33].”
BackgroundControl of poliomyelitis by pulse immunisation in Vellore, India.
John, T., Pandian, R. S., Gadomski, A., Steinhoff, M. C., John, M. M., & Ray, M. (1983) · BMJ · doi:10.1136/bmj.286.6358.31 · Cited by 35 · see citing works
Virus Excretion after Mass Vaccination with Attenuated Polioviruses in Hungary
Dömök, I., Molnar, E., & Jancsó, A. (1961) · BMJ · doi:10.1136/bmj.1.5237.1410 · Cited by 34 · see citing works
RNA Interference-Based Therapeutics: Molecular Platforms for Infectious Diseases
Dyawanapelly, S., Ghodke, S., Vishwanathan, R., Dandekar, P. P., & Jain, R. D. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2014.1929 · Cited by 31 · see citing works
SMITH, D. R. (2009) · Archives of Environmental & Occupational Health · doi:10.1080/19338240903293004 · Cited by 31 · see citing works
Eradication of Poliomyelitis in the United States. III. PoliovaccinesPractical Considerations
Salk, D. (1980) · Clinical Infectious Diseases · doi:10.1093/clinids/2.2.258 · Cited by 31 · see citing works
“t Data are from [50].”
Formulation technologies for oral vaccines
New, R. R. C. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13352 · Cited by 30 · see citing works
Kalkowska, D. A., Tebbens, R. J. D., & Thompson, K. M. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr399 · Cited by 29 · see citing works
Anti-Infectious Human Vaccination in Historical Perspective
D'Amelio, E., Salemi, S., & D’Amelio, R. (2015) · International Reviews of Immunology · doi:10.3109/08830185.2015.1082177 · Cited by 28 · see citing works
“Albert Sabin started his work on oral polio vaccine in 1953 and chose polio strains cultivated in cynomolgus monkey kidney, driven by the prior work of Ender’s group [92].”
BackgroundInfluentialTen citation classics from the New Zealand Medical Journal.
SMITH, D. R. (2007) · PubMed · Cited by 26 · see citing works
Prescott, J. B., Feldmann, H., & Safronetz, D. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.11.002 · Cited by 26 · see citing works
Mass Immunization Programs: Principles and Standards
Grabenstein, J. D., & Nevin, R. L. (2006) · Springer eBooks · doi:10.1007/3-540-36583-4_3 · Cited by 25 · see citing works
Eichner, M., & Hadeler, K. P. (1995) · Mathematical Biosciences · doi:10.1016/0025-5564(94)00046-3 · Cited by 25 · see citing works
Global Eradication of Poliovirus:History and Rationale
Dowdle, W. R., & Cochi, S. L. (2014) · ASM Press eBooks · doi:10.1128/9781555817916.ch38 · Cited by 24 · see citing works
Martinez, C. V., Old, M. O., Kwock, D., Khan, S. S., García, J. J., Chan, C. S., Webster, R. L., Halpern, M. S., & Maldonado, Y. (2004) · The Journal of Infectious Diseases · doi:10.1086/421703 · Cited by 23 · see citing works
Epidemiological Aspects of Coxsackie and Echo Virus Infections in Tropical Areas
Fox, J. P. (1964) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.54.7.1134 · Cited by 23 · see citing works
The Socialist World in Global Polio Eradication
Vargha, D. (2017) · Revue d’études comparatives Est-Ouest · doi:10.3917/receo1.491.0071 · Cited by 22 · see citing works
Sabin, A. B. (1991) · European Journal of Epidemiology · doi:10.1007/bf00237353 · Cited by 21 · see citing works
Self-citationVaccine-Preventable Disease and Immunization in the Developing World
Bart, K. J., & Lin, K. F.-Y. C. (1990) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)36913-9 · Cited by 22 · see citing works
Albert Sabin and the Coalition to Eliminate Polio From the Americas
Hampton, L. M. (2008) · American Journal of Public Health · doi:10.2105/ajph.2007.117952 · Cited by 21 · see citing works
The Potential Benefits of a new Poliovirus Vaccine for Long-Term Poliovirus Risk Management
Tebbens, R. J. D., & Thompson, K. M. (2016) · Future Microbiology · doi:10.2217/fmb-2016-0126 · Cited by 21 · see citing works
Asher, M. A. (1986) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)36145-4 · Cited by 21 · see citing works
Plotkin, S. A., Carp, R. I., & Graham, A. (1962) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1962.tb18877.x · Cited by 21 · see citing works
Sutter, R. W., Kew, O. M., Cochi, S. L., & Aylward, R. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00048-1 · Cited by 22 · see citing works
A quantitative survey of the literature on poliovirus infection and immunity
Behrend, M. R., Hu, H., Nigmatulina, K. R., & Eckhoff, P. A. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.09.005 · Cited by 19 · see citing works
Mir, F., Quadri, F., Mach, O., Ahmed, I., Bhatti, Z. S., Khan, A., Rehman, N. U., Durry, E., Salama, M., Oberste, S. M., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00093-6 · Cited by 18 · see citing works
Gnanashanmugam, D., Halpern, M. S., Dodge, A., Fang, M., Wong, L. J., Esparza, M., Hammon, R. J., Rivas-Merelles, E. E., Santos, J. I., & Maldonado, Y. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02268-06 · Cited by 17 · see citing works
“Vaccination using the trivalent, live attenuated oral poliomyelitis vaccine (OPV) led to the elimination of poliomyelitis in the United States and several regions of the world (15, 26).”
BackgroundIntestinal Viruses of Newborn and Older Prematures
Moscovici, C. (1961) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1961.04020070085012 · Cited by 17 · see citing works
Khanna, M., Jackson, R. J., Alcântara, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41506-5 · Cited by 16 · see citing works
Zaman, S., Carlsson, B., Jalil, F., Mellander, L., van Wezel, A. L., Böttiger, M., & Hanson, L. Å. (1991) · Acta Paediatrica · doi:10.1111/j.1651-2227.1991.tb11805.x · Cited by 16 · see citing works
“t ions a n d w a r m c l imate m a y fur ther deter iorate t h e s i tuat ion (9, 14-16).”
BackgroundIn vivo interference by Newcastle disease virus in chickens, the natural host of the virus
Li, X., & Hanson, R. P. (1989) · Archives of Virology · doi:10.1007/bf01310936 · Cited by 14 · see citing works
“Although it has long been suggested that live viral vaccine could provide protection soon after its administration by inducing viral interference, the details are not well understood [40, 41].”
BackgroundA MOSAIC OF ENTEROVIRUSES POLIOVIRUS, COXSACKIE, AND ECHO INFECTIONS IN A GROUP OF FAMILIES
Selwyn, S., & Lf, H. (1962) · The Lancet · doi:10.1016/s0140-6736(62)90416-6 · Cited by 14 · see citing works
Harb, J., Mennesson, N., Lepetit, C., Fourny, M., Louvois, M., Bosseboeuf, A., Allain‐Maillet, S., Decaux, O., Moreau, C., Tallet, A., et al. (2021) · Cells · doi:10.3390/cells10020438 · Cited by 13 · see citing works
Levine, M. M., Tapia, M. D., Hill, A. V. S., & Sow, S. O. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu513 · Cited by 12 · see citing works
Ecology of Enteroviruses in Tropics
Otatume, S., & Addy, P. A. K. (1975) · Japanese Journal of Microbiology · doi:10.1111/j.1348-0421.1975.tb00869.x · Cited by 12 · see citing works
Pioneering Figures in Medicine: Albert Bruce Sabin- Inventor of the Oral Polio Vaccine
SMITH, D. R., & Leggat, P. A. (2005) · The Kurume Medical Journal · doi:10.2739/kurumemedj.52.111 · Cited by 12 · see citing works
Toluca-1, a newly recognized enterovirus
Rosen, L., Schmidt, N. J., & Kern, J. (1973) · Archives of Virology · doi:10.1007/bf01242645 · Cited by 12 · see citing works
Community-Wide Type 3 Oral Poliovirus Vaccination in Atlanta, Ga., 1961
Gelfand, H. M. (1962) · JAMA · doi:10.1001/jama.1962.03050300001001 · Cited by 12 · see citing works
Fu, R., Altamirano, J., Sarnquist, C., Maldonado, Y., & Andrews, J. R. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy605 · Cited by 11 · see citing works
Mass Vaccination Against Poliomyelitis in Mexico
de Castro, J. F. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s397 · Cited by 11 · see citing works
“Shortly after oral poliovirus vaccine (OPV) was successfully tested in Toluca, Mexico, by Sabin and Ramos-Alvarez in 1959 [1], it was used in the”
MethodOccurrence of Echovirus 33 infections in Ontario.
Kelen, A. E., Lesiak, J. M., & Labzoffsky, N. A. (1968) · PubMed · Cited by 11 · see citing works
Stuart-Harris, C. H. (1962) · BMJ · doi:10.1136/bmj.1.5295.1779 · Cited by 11 · see citing works
Separation and assembly of deep sequencing data into discrete sub-population genomes
Karagiannis, K., Simonyan, V. V., Chumakov, K., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx755 · Cited by 10 · see citing works
“We validated using a sample of trivalent poliovirus vaccine made from a mixture of three serotypes of attenuated Sabin strains of poliovirus (25).”
MethodA LONGITUDINAL STUDY OF ENTEROVIRUS INFECTIONS IN KAWASAKI, JAPAN
Moritsugu, Y., Komatsu, T., KARASAWA, T., et al. (1970) · Japanese Journal of Medical Science and Biology · doi:10.7883/yoken1952.23.147 · Cited by 10 · see citing works
Mass Vaccination Against Polio
Hinman, A. R. (1984) · JAMA · doi:10.1001/jama.1984.03340460072029 · Cited by 10 · see citing works
Vaccine control of poliomyelitis in the 1980s.
SABIN, A. B. (1983) · PubMed · Cited by 10 · see citing works
Self-citationVariations in the prevalence of enterovirus infections in Ontario, 1956-1965.
Kelen, A. E., & Labzoffsky, N. A. (1967) · PubMed · Cited by 9 · see citing works
Barbosa, V., & Stewien, K. E. (1975) · Revista de Saúde Pública · doi:10.1590/s0034-89101975000200006 · Cited by 9 · see citing works
Polio vaccines and the cessation of vaccination
Minor, P. D. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.1.99 · Cited by 9 · see citing works
Citation indexing and the development of academic journals in tropical medicine
SMITH, D. R. (2008) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762008005000014 · Cited by 8 · see citing works
Enterovirus Infections in Healthy Children
Gelfand, H. M., & HOLGUIN, A. H. (1962) · Archives of Environmental Health An International Journal · doi:10.1080/00039896.1962.10663305 · Cited by 8 · see citing works
Eradication of Polio by Vaccination
Minor, P. D. (2000) · Virology · doi:10.1006/viro.2000.0208 · Cited by 7 · see citing works
“The successful strategy developed in South America in the 1970s and 1980s was first proposed by Sabin in 1960 (Sabin et al., 1960).”
BackgroundEradication and cessation of programmes
Minor, P. D. (2002) · British Medical Bulletin · doi:10.1093/bmb/62.1.213 · Cited by 7 · see citing works
Poliomyelitis vaccination in Ibadan, Nigeria, during 1964 with oral vaccine (Sabin strains).
(1966) · PubMed · Cited by 7 · see citing works
Epidemiological Implications of Rubella "Vaccine Failures"
Wilkins, J. (1972) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1972.02110070081009 · Cited by 7 · see citing works
- Authors
- Sabin, A. B.
- Corresponding author
- Sabin, Albert B.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1960-08-06
- Volume
- 173
- Issue
- 14
- Pages
- 1521
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2069543300
- Cited by
- 182
- References
- 0
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 1 · 2019: 3 · 2018: 16 · 2017: 4 · 2016: 5 · 2015: 3 · 2014: 11 · 2013: 4 · 2012: 4
- FWCI
- 11.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- live poliovirus vaccine, viral interference, trivalent oral polio vaccine, polio eradication, mass vaccination campaigns, enteric viruses, tropical and subtropical regions
- MeSH terms
- Humans, Poliomyelitis, Viruses, Mass Vaccination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
